1. Home
  2. SNGX vs BESS Comparison

SNGX vs BESS Comparison

Compare SNGX & BESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.16

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$2.95

Market Cap

16.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SNGX
BESS
Founded
1987
1998
Country
United States
United States
Employees
N/A
3
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
16.2M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
BESS
Price
$1.16
$2.95
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
174.9K
31.8K
Earning Date
05-08-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$2.06
52 Week High
$6.23
$3.60

Technical Indicators

Market Signals
Indicator
SNGX
BESS
Relative Strength Index (RSI) 48.10 55.35
Support Level $1.11 $2.51
Resistance Level $1.22 $3.23
Average True Range (ATR) 0.05 0.34
MACD 0.00 0.05
Stochastic Oscillator 57.58 76.92

Price Performance

Historical Comparison
SNGX
BESS

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

Share on Social Networks: